GGrantIndex
← Leaderboards

Elie Haddad

University Of California, San Francisco

$1,288,114
Attributed
$4,152,452
Total exposure
2
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,561,239 · 3

By mechanism

U54$7,980,817 · 2
R24$3,580,422 · 1

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Caring

Research focus

CaringT-LymphocyteProspectiveFutureGenotypeLate EffectsSamplingGene TherapyEnzyme Replacement TherapyChimerismSevere Combined ImmunodeficiencyDesignSeveritiesB-LymphocytesProtocols DocumentationQuality Of LifePreventBaseImmuneImmunityGrowthImmunologyCellsEvidence Base

Grant awards (12)

Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity$1,743,065
R24 · FY2025 · AI
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity$21,475
R24 · FY2025 · AI
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity$1,815,882
R24 · FY2024 · AI
Primary Immune Deficiency Treatment Consortium$1,846,257
U54 · FY2023 · AI
Primary Immune Deficiency Treatment Consortium$1,846,257
U54 · FY2022 · AI
Primary Immune Deficiency Treatment Consortium$1,846,474
U54 · FY2021 · AI
Primary Immune Deficiency Treatment Consortium$1,869,799
U54 · FY2020 · AI
A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1,1968$30,521
U54 · FY2018 · AI · contact PI
A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1,1968$442,133
U54 · FY2017 · AI · contact PI
A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1,1968$29,111
U54 · FY2016 · AI · contact PI
A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1,1968$29,111
U54 · FY2015 · AI · contact PI
A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1,1968$41,154
U54 · FY2014 · AI · contact PI